Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C8H12N2O3 |
Molecular Weight | 184.1925 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)\C=C(/C)N[C@@H]1CONC1=O
InChI
InChIKey=DGYLXKOLHICICX-OHCKJTPYSA-N
InChI=1S/C8H12N2O3/c1-5(3-6(2)11)9-7-4-13-10-8(7)12/h3,7,9H,4H2,1-2H3,(H,10,12)/b5-3+/t7-/m1/s1
Molecular Formula | C8H12N2O3 |
Molecular Weight | 184.1925 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Pentizidone is a prodrug which is hydrolyzed spontaneously and converted to D-cycloserine. Merck selected pentizidone as a companion product for D-fluoroalanine with the anticipation that it would be better tolerated than cycloserine itself. The expectation was that D-fluoroalanine and pentizidone would be synergistic in killing bacteria. The combination of the two enzyme inhibitors proved to have potent antibiotic activity in animal studies and abolished the self-reversal phenomenon. D-cycloserine acts on D-alanyl-D-alanine synthetase.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
In vitro activity of fludalanine combined with pentizidone compared with those of other agents. | 1984 May |
|
Experimental pneumonia due to Haemophilus influenzae: observations on pathogenesis and treatment. | 1984 May |
|
Simultaneous quantification of cycloserine and its prodrug acetylacetonylcycloserine in plasma and urine by high-performance liquid chromatography using ultraviolet absorbance and fluorescence after post-column derivatization. | 1987 Feb 20 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:38:47 GMT 2023
by
admin
on
Fri Dec 15 18:38:47 GMT 2023
|
Record UNII |
0UP011P7BS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000082516
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
SUB09698MIG
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
DTXSID601023944
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
4248
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
C166438
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
CHEMBL2111012
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
55694-83-2
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
0UP011P7BS
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
C052306
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY | |||
|
6441072
Created by
admin on Fri Dec 15 18:38:47 GMT 2023 , Edited by admin on Fri Dec 15 18:38:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |